Kyle Mikson
Stock Analyst at Canaccord Genuity
(0)
# 4872
Out of 5,240 analysts
78
Total ratings
14.89%
Success rate
-28.35%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Exagen | Maintains: Strong Buy | 5 7 | 3 | 133.33% | 2 | Jan 3, 2025 | |
Natera | Maintains: Strong Buy | 165 180 | 169.09 | 6.45% | 6 | Jan 3, 2025 | |
Repligen | Initiates Coverage On: Hold | 165 | 158 | 4.43% | 1 | Dec 17, 2024 | |
Akoya Biosciences | Maintains: Buy | 6 4 | 2.72 | 28.68% | 3 | Nov 15, 2024 | |
Lucid Diagnostics | Maintains: Buy | 3 3 | 0.82 | 265.85% | 4 | Nov 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 2 1 | 2.38 | -57.98% | 3 | Nov 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 95 75 | 55.63 | 34.82% | 9 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 130 145 | 138.78 | 4.48% | 6 | Nov 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 35 42 | 25.95 | 61.85% | 3 | Oct 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 32 20 | 16.09 | 24.3% | 6 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | 1.94 | 54.64% | 7 | Aug 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 3 5 | 0.29 | 1624.14% | 3 | Jul 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 30 38 | 38.75 | -1.94% | 4 | Jun 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 32 25 | 8.67 | 188.35% | 4 | Apr 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | 26 | n/a | n/a | 2 | Mar 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 4 | 1.15 | 204.35% | 2 | Mar 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 2 | n/a | n/a | 4 | Nov 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 3 | n/a | n/a | 4 | Sep 25, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 3 2 | 0.66 | 203.03% | 2 | Aug 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 50 | 0.6 | 8100% | 1 | Mar 30, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 19 | 1.99 | 854.77% | 1 | Jan 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 150 | 0.55 | 27172.73% | 1 | Jan 29, 2021 |